Written Question·Department of Health and Social Care·UIN 98244

Liothyronine

Tabled: 8 December 2025

Answered: 17 December 2025

Question

Anna Sabine

Liberal Democrat — Frome and East Somerset

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that NHSE informs ICBs, practitioners and Regional Pharmacists about amendments to the liothyronine (T3) section in the guidance document entitled Items which shou

Answer

Dr Zubir Ahmed

Regional chief pharmacists have been informed of the changes made to the liothyronine section, including Armour Thyroid and liothyronine combination products, of the ‘items that should not be prescribed in primary care’ policy guidance via email. They hav...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 98244) →